Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
Long-term effects of intensive glucose lowering on cardiovascular outcomes
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
Short-Term Progression of Multiterritorial Subclinical Atherosclerosis
Antithrombotic Therapy for Atherosclerotic Cardiovascular Disease Risk Mitigation in Patients With Coronary Artery Disease and Diabetes Mellitus
Negative Risk Markers for Cardiovascular Events in the Elderly
Baseline Characteristics and Risk Profiles of Participants in the ISCHEMIA Randomized Clinical Trial
Diagnostic accuracy of cardiac positron emission tomography versus single photon emission computed tomography for coronary artery disease: a bivariate meta-analysis
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.